J

Jounce Therapeutics, Inc.

117 employees

Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Cancer Immunotherapy
Immunology
Therapeutics
Antibody Development
Oncology
Pharmaceutical

Date founded

2013

Funding rounds raised

Total raised

$56M

from 8 investors over 8 rounds

J

Jounce Therapeutics, Inc. raised $56M on April 23, 2015

Investors: Omega Funds, Nextech Invest, Casdin Capital, LLC, Inbio Ventures, Redmile Group, Wellington Management and Foresite Capital

J

Jounce Therapeutics, Inc. raised $47M on February 14, 2013

Investors: Third Rock Ventures

FAQ